...
首页> 外文期刊>Iranian red crescent medical journal >A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity
【24h】

A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity

机译:右美托咪定,莫索尼定和α-甲基多巴对急性,致命可卡因毒性的作用比较

获取原文

摘要

The treatment of cocaine toxicity is an important subject for emergency physicians. We investigated the effects of dexmedetomidine, moxonidine and alpha-methyldopa on acute cocaine toxicity in mice. Objectives: The aim of this study was to evaluate the effects of dexmedetomidine, moxonidine and alpha-methyldopa in a mouse model of acute cocaine toxicity. Materials and Methods: We performed an experiment consisting of four groups (n = 25 each). The first group received normal saline solution, the second group received 40 μg/kg of dexmedetomidine, the third group received 0.1 mg/kg of moxonidine and the fourth group received 200 mg/kg of alpha-methyldopa, all of which were intraperitoneally administered 10 minutes before cocaine hydrochloride (105 mg/kg). All animals were observed for seizures (popcorn jumping, tonic-clonic activity, or a loss of the righting reflex) and lethality over the 30 minutes following cocaine treatment. Results: The ratio of animals with convulsions was lower in all treated groups when compared to the control (P < 0.001). Furthermore, 68% (n = 17) of animals in the dexmedetomidine group, 84% (n = 21) of the alpha-methyldopa group, 92% (n = 23) of the moxonidine group and 100% (n = 25) of the control group showed evidence of seizure activity (P = 0.009). Cocaine-induced lethality was observed in 12% (n = 3) of the dexmedetomidine group, 48% (n = 12) of the alpha-methyldopa group, 52% (n = 13) of the moxonidine group, and 72% (n = 18) of the control group (P < 0.001). All treatments prolonged the time to seizure, which was longest in the dexmedetomidine group (P > 0.05). In addition, the time to lethality was also longer in the same group (P < 0.001). Conclusions: The present study provides the first experimental evidence in support of dexmedetomidine treatment for cocaine-induced seizures. Premedication with dexmedetomidine reduces seizure activity in a mouse model of acute cocaine toxicity. In addition, while dexmedetomidine may be effective, moxonidine and alpha-methyldopa did not effectively prevent cocaine-induced lethality.
机译:可卡因毒性的治疗是急诊医师的重要课题。我们调查了右美托咪定,莫索尼定和α-甲基多巴对小鼠可卡因急性毒性的影响。目的:本研究旨在评估右美托咪定,莫索尼定和α-甲基多巴在急性可卡因毒性小鼠模型中的作用。材料和方法:我们进行了一个由四组组成的实验(每组n = 25)。第一组接受生理盐水,第二组接受40μg/ kg右美托咪定,第三组接受0.1 mg / kg的莫索尼定,第四组接受200 mg / kg的α-甲基多巴,所有这些均通过腹膜内给药10盐酸可卡因(105 mg / kg)前几分钟。在可卡因治疗后的30分钟内,观察所有动物的癫痫发作(爆米花跳跃,强直性阵挛性活动或正向反射力丧失)和致死率。结果:与对照组相比,所有治疗组中惊厥动物的比例均较低(P <0.001)。此外,右美托咪定组中有68%(n = 17)的动物,α-甲基多巴组中有84%(n = 21),莫索尼定组有92%(n = 23)和100%(n = 25)对照组显示有癫痫发作的迹象(P = 0.009)。在12%(n = 3)的右美托咪定组,48%(n = 12)的α-甲基多巴组,52%(n = 13)的莫索尼定组和72%(n = 18)的对照组(P <0.001)。所有治疗均延长了癫痫发作时间,这在右美托咪定组中最长(P> 0.05)。此外,同一组的致死时间也更长(P <0.001)。结论:本研究提供了第一个实验证据,支持右美托咪定治疗可卡因诱发的癫痫发作。在急性可卡因毒性的小鼠模型中,右美托咪定的用药减少了癫痫发作的活性。此外,尽管右美托咪定可能是有效的,但莫索尼定和α-甲基多巴并不能有效防止可卡因诱发的致死性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号